Our patient-centric vision at Jazz is a world where all patients and their caregivers have the power to achieve outcomes that matter most to them. We are committed to understanding the challenges and opportunities which most impact people living with complex sleep conditions, like narcolepsy and idiopathic hypersomnia.
We are proud to continuously generate novel, clinically relevant data from real-world and clinical trials, including our extensive Phase 4 programs, which build on existing evidence such as sleep architecture and the cardiovascular and cardiometabolic risks associated with sleep conditions. The design of these studies is informed by direct feedback from people living with narcolepsy or idiopathic hypersomnia and considers the holistic challenges those living with these conditions, their family members and caregivers may face daily.
These findings offer critical new data that shed a light on the lived experiences of individuals managing these challenging sleep conditions and can play a meaningful role in informing shared decision-making between healthcare professionals and people living with sleep conditions on their treatment options and management plans.
At Jazz, we are consistently reminded of how support and collaborations with the sleep community are central to our purpose. Support for organizations across the sleep community, including American Academy of Sleep Medicine, the Sleep Research Society, and the Hypersomnia Foundation, are integral to making a difference in the realities of people living with sleep conditions. Supporting these organizations and professional societies helps provide opportunities for individuals to share their lived experiences and shed light on the profound impact of their condition.
Collaborations like these are key to not only understanding the experiences of people with sleep conditions but also to developing patient-centric innovations that help address their symptoms.
In my role as Sleep Franchise Head, I am more committed than ever to strengthening Jazz’s approach to patient-centricity and finding new ways to ensure the lived experiences of people with sleep conditions are at the heart of our work.
I look forward to the opportunity to connect with the sleep community and learn from leading experts while also contributing to the ongoing conversation about improving the outcomes of people with challenging sleep conditions. I am deeply inspired by the dedication and hard work of my colleagues, whose contributions are pivotal as we remain pioneers in sleep medicine and strive to make a lasting impact on patient care.
الإبلاغ عن أثر جانبي
إذا كنت ترغب في الإبلاغ عن أثر جانبي مرتبط بالمنتجات الدوائية لشركة Jazz Pharmaceuticals، يُرجى إرسال بريد إلكتروني إلينا عبر الرابط التالي:
يُرجى تقديم أكبر قدر ممكن من المعلومات المتاحة.
تشمل المعلومات ذات الصلة ما يلي:
بتقديمك لتقريرك وتزويدنا ببيانات الاتصال الخاصة بك، فإنك تُقرّ وتوافق صراحةً على أنه يجوز لقسم السلامة الدوائية المحلي التواصل معك بغرض طلب معلومات إضافية أو توضيحات، إذا اعتُبر ذلك ضروريًا لتقييم التقرير ومتابعته.
يوضح إشعار الخصوصية الخاص بنا المتعلق باليقظة الدوائية والمعلومات الطبية وشكاوى المنتجات كيفية تعامل شركة Jazz Pharmaceuticals مع معالجة المعلومات الشخصية عند التعامل مع تقريرالأثر الجانبي الخاص بك، وهو متاح في مركز الخصوصية لدينا.
Report an Adverse Event
If you want to report a Adverse Event related to Jazz Pharmaceuticals medicinal products, then please send us an e-mail via this link:
Please provide as much available information as possible.
Relevant information includes:
By submitting your report and providing your contact details, you expressly acknowledge and agree that the local drug safety department may contact you for the purpose of requesting additional information or clarifications, should this be deemed necessary for the assessment and follow‑up of the report.
Our Privacy Notice for Pharmacovigilance, Medical Information and Product Complaints outlines how Jazz Pharmaceuticals handles the processing of personal information when dealing with your adverse event report and is available in our Privacy Center.
